Orexo AB Valuation
| ORX Stock | SEK 9.55 0.15 1.60% |
At this time, the company appears to be undervalued. Orexo AB holds a recent Real Value of kr10.95 per share. The prevailing price of the company is kr9.55. Our model determines the value of Orexo AB from analyzing the company fundamentals such as Return On Equity of -0.65, operating margin of (0.29) %, and Shares Outstanding of 34.35 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Orexo AB's price fluctuation is not too volatile at this time. Calculation of the real value of Orexo AB is based on 3 months time horizon. Increasing Orexo AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Orexo AB's intrinsic value may or may not be the same as its current market price of 9.55, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.55 | Real 10.95 | Hype 9.55 | Naive 9.75 |
The intrinsic value of Orexo AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Orexo AB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Orexo AB helps investors to forecast how Orexo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Orexo AB more accurately as focusing exclusively on Orexo AB's fundamentals will not take into account other important factors: Orexo AB Total Value Analysis
Orexo AB is now anticipated to have takeover price of 795.36 M with market capitalization of 612.75 M, debt of 519 M, and cash on hands of 697 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Orexo AB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
795.36 M | 612.75 M | 519 M | 697 M |
Orexo AB Investor Information
About 17.0% of the company outstanding shares are owned by corporate insiders. The book value of Orexo AB was now reported as 5.64. The company recorded a loss per share of 6.28. Orexo AB had not issued any dividends in recent years. The entity had 1904:1903 split on the 31st of May 2011. Based on the measurements of operating efficiency obtained from Orexo AB's historical financial statements, Orexo AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Orexo AB Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Orexo AB has an asset utilization ratio of 56.29 percent. This implies that the Company is making kr0.56 for each dollar of assets. An increasing asset utilization means that Orexo AB is more efficient with each dollar of assets it utilizes for everyday operations.Orexo AB Ownership Allocation
Orexo AB owns a total of 34.35 Million outstanding shares. 30% of Orexo AB outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Orexo AB Profitability Analysis
The company reported the revenue of 624.3 M. Net Loss for the year was (183.9 M) with profit before overhead, payroll, taxes, and interest of 521.7 M.About Orexo AB Valuation
The stock valuation mechanism determines Orexo AB's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Orexo AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orexo AB. We calculate exposure to Orexo AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Orexo AB's related companies.Orexo AB , a specialty pharmaceutical company, develops products based on proprietary drug delivery technology. Orexo AB was founded in 1995 and is headquartered in Uppsala, Sweden. Orexo AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 130 people.
8 Steps to conduct Orexo AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Orexo AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Orexo AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Orexo AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Orexo AB's revenue streams: Identify Orexo AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Orexo AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Orexo AB's growth potential: Evaluate Orexo AB's management, business model, and growth potential.
- Determine Orexo AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Orexo AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Orexo Stock Analysis
When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.